1)Treatment of age-related macular degeneration with photodynamic therapy(TAP)Study Group:Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin;one-year results of 2 randomized clinical trials;TAP report. Arch Ophthalmol 117:1329-1345, 1999
2)Japanese Age-Related Macular Degeneration Trial:One-year results of photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration. Am J Ophthalmol 136:1049-1061, 2003
3)Gonzales CR, and VEGF Inhibition Study in Ocular Neovascularization(VISION)Clinical Trial Group:Enhanced efficacy associated with early treatment of neovascular age-related macular degeneration with pegaptanib sodium;an exploratory analysis. Retina 25:815-827, 2005
4)ペガプタニブナトリウム共同試験グループ:脈絡膜新生血管を伴う加齢黄斑変性を対象としたペガプタニブナトリウム1年間投与試験.日眼会誌 112:590-600,2008
5)Rosenfeld PJ, Brown DM, Heier JS et al, and MARINA Study Group:Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419-1431, 2006
6)Brown DM, Kaiser PK, Michels M et al, and ANCHOR Study Group:Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355:1432-1444, 2006
7)Kaiser PK, Boyer DS, Garcia R et al:Verteporfin photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration. Ophthalmology 116:747-755, 2009
8)Sato T, Kishi S, Matsumoto H et al:Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for polypoidal choroidal vasculopathy. Am J Ophthalmol 149:947-954, 2010
9)Gomi F, Sawa M, Wakabayashi T et al:Efficacy of intravitreal bevacizumab combined with photodynamic therapy for polypoidal choroidal vasculo-pathy. Am J Ophthalmol 150:48-54, 2010